{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:44:26Z","timestamp":1770979466398,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007207","name":"Toray Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007207","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Veterinary Science"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.rvsc.2020.08.007","type":"journal-article","created":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T19:22:38Z","timestamp":1596914558000},"page":"466-473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The inhibitory effect of canine interferon gamma on the growth of canine tumors"],"prefix":"10.1016","volume":"132","author":[{"given":"Yuki","family":"Hamamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Igase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rvsc.2020.08.007_bb0005","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1172\/JCI111292","article-title":"Gamma interferon induces monocytoid differentiation in the HL-60 cell line","volume":"73","author":"Ball","year":"1984","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0010","first-page":"587","article-title":"Gamma-interferon induces apoptosis of the B lymphoma WEHI-279 cell line through a CD95\/CD95L-independent mechanism","volume":"12","author":"Ben Jilani","year":"2001","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00368183","article-title":"Differential sensitivity of renal cell carcinoma xenografts towards therapy with interferon-alpha, interferon-gamma, tumor necrosis factor and their combinations","volume":"19","author":"Beniers","year":"1991","journal-title":"Urol. Res."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0020","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/sj.cgt.7700625","article-title":"Enhancing antimelanoma immune responses through apoptosis","volume":"10","author":"Bianco","year":"2003","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0025","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.15.1.749","article-title":"Cellular responses to interferon-gamma","volume":"15","author":"Boehm","year":"1997","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0030","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/sj.bjc.6690491","article-title":"Cytotoxic response of ovarian cancer cell lines to IFN-gamma is associated with sustained induction of IRF-1 and p21 mRNA","volume":"80","author":"Burke","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.rvsc.2020.08.007_bb0035","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1084\/jem.177.1.213","article-title":"Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia","volume":"177","author":"Buschle","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0040","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1126\/science.272.5262.719","article-title":"Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1\/CIP1 mediated by STAT1","volume":"272","author":"Chin","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.rvsc.2020.08.007_bb0045","first-page":"5789","article-title":"Loss of interferon-gamma inducibility of TAP1 and LMP2 in a renal cell carcinoma cell line","volume":"60","author":"Dovhey","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0050","doi-asserted-by":"crossref","first-page":"421","DOI":"10.7326\/0003-4819-106-3-421","article-title":"NIH conference. Immunomodulators in clinical medicine","volume":"106","author":"Fauci","year":"1987","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0055","first-page":"335","article-title":"The role of p21 in interferon gamma-mediated growth inhibition of human breast cancer cells","volume":"11","author":"Gooch","year":"2000","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0060","doi-asserted-by":"crossref","first-page":"399","DOI":"10.7326\/0003-4819-93-3-399","article-title":"Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma","volume":"93","author":"Gutterman","year":"1980","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0065","first-page":"289","article-title":"Gamma-interferon induces an irreversible growth arrest in mid-G1 in mammary epithelial cells which correlates with a block in hyperphosphorylation of retinoblastoma","volume":"7","author":"Harvat","year":"1996","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0070","doi-asserted-by":"crossref","first-page":"24869","DOI":"10.1074\/jbc.M109.025932","article-title":"Mechanisms of resistance to interferon-gamma-mediated cell growth arrest in human oral squamous carcinoma cells","volume":"284","author":"Hiroi","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0075","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1359-6101(01)00038-7","article-title":"The roles of IFN\u03b3 in protection against tumor development and cancer immunoediting","volume":"13","author":"Ikeda","year":"2002","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0080","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1292\/jvms.66.1437","article-title":"Establishment and characterization of four canine melanoma cell lines","volume":"66","author":"Inoue","year":"2004","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0085","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.prevetmed.2015.03.018","article-title":"A current life table and causes of death for insured dogs in Japan","volume":"120","author":"Inoue","year":"2015","journal-title":"Prev. Vet. Med."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0090","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1038\/sj.onc.1202217","article-title":"IFNgamma inhibition of cell growth in glioblastomas correlates with increased levels of the cyclin dependent kinase inhibitor p21WAF1\/CIP1","volume":"17","author":"Kominsky","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.rvsc.2020.08.007_bb0095","first-page":"1258","article-title":"Antitumor effect of recombinant human interferon-beta and interferon-gamma in combination against human colon cancer cell line in vitro and in nude mice","volume":"78","author":"Kondo","year":"1987","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0100","first-page":"1234","article-title":"Combined effect of human recombinant interferon alpha, beta and gamma on tumor cell growth and the cell cycle in vitro","volume":"14","author":"Kondo","year":"1987","journal-title":"Gan To Kagaku Ryoho"},{"key":"10.1016\/j.rvsc.2020.08.007_bb0105","first-page":"1400","article-title":"Antitumor effect of human recombinant interferon-gamma alone and in combination with adriamycin on a human colon cancer cell line (RPMI 4788) in vitro and in nude mice","volume":"78","author":"Kondo","year":"1987","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0110","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1046\/j.0022-202X.2004.22237.x","article-title":"Interferon-gamma-mediated growth regulation of melanoma cells: involvement of STAT1-dependent and STAT1-independent signals","volume":"122","author":"Kortylewski","year":"2004","journal-title":"J. Invest Dermatol."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0115","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1182\/blood.V70.4.943.943","article-title":"Therapy of chronic myelogenous leukemia with recombinant interferon-gamma","volume":"70","author":"Kurzrock","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.rvsc.2020.08.007_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043355","article-title":"Genomic instability and telomere fusion of canine osteosarcoma cells","volume":"7","author":"Maeda","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.rvsc.2020.08.007_bb0125","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/sj.onc.1201529","article-title":"Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK)","volume":"16","author":"Mandal","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.rvsc.2020.08.007_bb0130","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF02924542","article-title":"Antiproliferative effects of natural human tumor necrosis factor-alpha, interferon-alpha, and interferon-gamma on human pancreatic carcinoma cell lines","volume":"8","author":"Matsubara","year":"1991","journal-title":"Int. J. Pancreatol."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0135","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1939-1676.2008.0133.x","article-title":"Cancer incidence in pet dogs: findings of the animal tumor registry of Genoa, Italy","volume":"22","author":"Merlo","year":"2008","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0140","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1749-6632.2009.05069.x","article-title":"Clinical use of interferon-gamma","volume":"1182","author":"Miller","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0145","doi-asserted-by":"crossref","first-page":"7093","DOI":"10.1158\/0008-5472.CAN-10-0600","article-title":"IFN{gamma} markedly cooperates with intratumoral dendritic cell vaccine in dog tumor models","volume":"70","author":"Mito","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0150","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.rvsc.2013.09.007","article-title":"Effect of rCaIFN-{gamma} on NK cytotoxic activity in the peripheral blood of dogs","volume":"95","author":"Miyata","year":"2013","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0155","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.rvsc.2005.07.011","article-title":"Cyclopedic protein expression analysis of cultured canine mammary gland adenocarcinoma cells from six tumours","volume":"80","author":"Nakagawa","year":"2006","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0160","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1292\/jvms.58.469","article-title":"Establishment and characterization of a new canine B-cell leukemia cell line","volume":"58","author":"Nakaichi","year":"1996","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0165","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.vetimm.2008.06.014","article-title":"Identification of c-kit mutations-independent neoplastic cell proliferation of canine mast cells","volume":"126","author":"Ohmori","year":"2008","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0170","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1146\/annurev.bi.56.070187.003455","article-title":"Interferons and their actions","volume":"56","author":"Pestka","year":"1987","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM198401053100104","article-title":"Alpha interferon for induction of remission in hairy-cell leukemia","volume":"310","author":"Quesada","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0180","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/0008-8749(88)90194-3","article-title":"Cytolytic activity of murine anti-dog lymphoma monoclonal antibodies with canine effector cells and complement","volume":"115","author":"Rosales","year":"1988","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0185","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.leukres.2010.01.021","article-title":"Establishment and characterization of a novel canine B-cell line derived from a spontaneously occurring diffuse large cell lymphoma","volume":"34","author":"Rutgen","year":"2010","journal-title":"Leuk. Res."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0190","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/sj.onc.1200832","article-title":"Induction of Cip\/kip and Ink4 cyclin dependent kinase inhibitors by interferon-alpha in hematopoietic cell lines","volume":"14","author":"Sangfelt","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.rvsc.2020.08.007_bb0195","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1182\/blood.V91.2.570","article-title":"Interferon-alpha resistance in a cutaneous T-cell lymphoma cell line is associated with lack of STAT1 expression","volume":"91","author":"Sun","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.rvsc.2020.08.007_bb0200","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1158\/1078-0432.CCR-04-1944","article-title":"In vitro canine distemper virus infection of canine lymphoid cells: a prelude to oncolytic therapy for lymphoma","volume":"11","author":"Suter","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0205","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000053820","article-title":"IgG-mediated histamine release from canine mastocytoma-derived cells","volume":"125","author":"Takahashi","year":"2001","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0210","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.7150\/ijbs.4694","article-title":"Interferon-gamma-induced nitric oxide inhibits the proliferation of murine renal cell carcinoma cells","volume":"8","author":"Tate","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0215","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3389\/fonc.2019.01257","article-title":"Canine cancer: strategies in experimental therapeutics","volume":"9","author":"Thamm","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0220","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1292\/jvms.12-0448","article-title":"Establishment of five canine lymphoma cell lines and tumor formation in a xenotransplantation model","volume":"75","author":"Umeki","year":"2013","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0225","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/sj.onc.1204199","article-title":"Control of cell cycle progression in human mesothelioma cells treated with gamma interferon","volume":"20","author":"Vivo","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.rvsc.2020.08.007_bb0230","doi-asserted-by":"crossref","first-page":"28779","DOI":"10.1074\/jbc.272.45.28779","article-title":"Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3gamma","volume":"272","author":"Wong","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.rvsc.2020.08.007_bb0235","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1182\/blood.V84.6.1942.1942","article-title":"Primary leukemia cells resistant to alpha-interferon in vitro are defective in the activation of the DNA-binding factor interferon-stimulated gene factor 3","volume":"84","author":"Xu","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.rvsc.2020.08.007_bb0240","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-3164.2009.00764.x","article-title":"Low-dose recombinant canine interferon-gamma for treatment of canine atopic dermatitis: an open randomized comparative trial of two doses","volume":"21","author":"Yasukawa","year":"2010","journal-title":"Vet. Dermatol."}],"container-title":["Research in Veterinary Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528820309796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528820309796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T04:24:09Z","timestamp":1758515049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0034528820309796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":48,"alternative-id":["S0034528820309796"],"URL":"https:\/\/doi.org\/10.1016\/j.rvsc.2020.08.007","relation":{},"ISSN":["0034-5288"],"issn-type":[{"value":"0034-5288","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The inhibitory effect of canine interferon gamma on the growth of canine tumors","name":"articletitle","label":"Article Title"},{"value":"Research in Veterinary Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rvsc.2020.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}